Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

531681

AMERISE

img img img img
No Data Available

AMERISE BIOSCIENCES LIMITED Share Price Update

As of the latest trading session, AMERISE BIOSCIENCES LIMITED share price is currently at ₹ 0.79, which is up by ₹ 0.10 from its previous closing. Today, the stock has fluctuated between ₹ 0.78 and ₹ 0.80. Over the past year, AMERISE BIOSCIENCES LIMITED has achieved a return of -31.00 %. In the last month alone, the return has been 7.81 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

AMERISE BIOSCIENCES LIMITED fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    5.20

  • P/E Ratio (TTM)

    69.00

  • Beta

    0.54

  • Book Value / share

    0.80

  • Return on equity

    0.17%

  • EPS (TTM)

    0.01

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.01

info icon alternate text

AMERISE BIOSCIENCES LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit 0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.01
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit -0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.01
EBITDA -0.04
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.07
Net Profit -0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA -0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.08
Net Profit 0.11
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.02
EBITDA 0.11
Effective Tax Rate (%) 0.00
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.02
Net Profit -0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA -0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.18
Net Profit 0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.01
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.18
Net Profit -0.15
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.15
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.13
Net Profit -0.12
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.02
EBITDA -0.12
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 9.01
Operating Expense 9.03
Net Profit 0.55
Net Profit Margin (%) 6.10
Earnings Per Share (EPS) 0.08
EBITDA 0.55
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.17
Net Profit -0.34
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.05
EBITDA -0.34
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 0.81
ROE % 0.17
ROCE % 0.17
Total Debt to Total Equity 0.00
EBITDA Margin 5.26
Particulars MAR 2024 (Values in Cr)
Book Value / Share 0.81
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin -375.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 0.84
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.02
EBITDA Margin -1200.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 0.85
ROE % 9.34
ROCE % 9.27
Total Debt to Total Equity 0.01
EBITDA Margin 5.74
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.77
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 8.46
Total Liabilities 8.46
Total Equity 5.37
Share Outstanding 6
Price to Book Ratio 1.12
Return on Assets (%) 0.06
Return on Capital (%) 0.11
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 5.38
Total Liabilities 5.38
Total Equity 5.37
Share Outstanding 6
Price to Book Ratio 0.81
Return on Assets (%) -2.71
Return on Capital (%) -2.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 5.64
Total Liabilities 5.64
Total Equity 5.52
Share Outstanding 6
Price to Book Ratio 0.83
Return on Assets (%) -2.10
Return on Capital (%) -2.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 11.98
Total Liabilities 11.98
Total Equity 5.63
Share Outstanding 6
Price to Book Ratio 1.60
Return on Assets (%) 4.58
Return on Capital (%) 9.6
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 5.62
Total Liabilities 5.62
Total Equity 5.09
Share Outstanding 6
Price to Book Ratio 2.14
Return on Assets (%) -5.99
Return on Capital (%) -6.62
Particulars MAR 2025 (Values in Cr)
Net Income 0.00
Cash from Operations 3.07
Cash from Investing -3.06
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 3.07
Particulars MAR 2024 (Values in Cr)
Net Income -0.14
Cash from Operations -0.16
Cash from Investing 0.26
Cash from Financing -0.09
Net change in Cash 0.00
Free Cash Flow -0.16
Particulars MAR 2023 (Values in Cr)
Net Income -0.11
Cash from Operations -0.13
Cash from Investing 0.12
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow -0.13
Particulars MAR 2022 (Values in Cr)
Net Income 0.54
Cash from Operations 0.06
Cash from Investing -0.15
Cash from Financing 0.08
Net change in Cash 0.00
Free Cash Flow 0.06
Particulars MAR 2021 (Values in Cr)
Net Income -0.33
Cash from Operations -0.39
Cash from Investing 0.38
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow -0.39
Company Name Price P/E P/B Market Cap 52 Week Low/High
ALFRED HERBERT (INDIA) LTD. 2726.85 8.72 0.37 209.97 1810.00 / 3974.00
BAJAJ HOLDINGS & INVESTMENT LT 10926.15 17.18 1.79 121597.12 10406.00 / 14873.20
TATA INVESTMENT CORP LTD 633.80 78.64 1.00 32067.30 514.72 / 1184.00
Naperol Investments Limited 1437.10 23.31 0.90 825.90 801.00 / 2041.00
[-] 0.0 0.0 0.0 0.0 0.0 / 0.0
Company Name Price P/E P/B Market Cap 52 Week Low/High
ALFRED HERBERT (INDIA) LTD. 2726.85 8.79 0.38 209.97 1810.00 / 3974.00
ARAVALI SECURITIES & FINANCE L 3.68 0.00 -5.47 5.58 3.44 / 5.09
BAJAJ HOLDINGS & INVESTMENT LT 10926.15 46.93 5.34 121597.12 10406.00 / 14873.20
GKW LIMITED 1689.40 0.00 2.62 1008.57 1371.00 / 2262.00

AMERISE BIOSCIENCES LIMITED shareholding pattern

Holding

100.0%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

AMERISE BIOSCIENCES LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
0.79 14.49 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 0.60
  • 26 Days 0.60
  • 10 Days 0.60
  • 50 Days 0.60
  • 12 Days 0.60
  • 100 Days 0.70
  • 20 Days 0.60
  • 200 Days 0.70
0.68 PIVOT

First Support

0.67

First Resistance

0.70

Second Support

0.65

Second Resistance

0.71

Third Support

0.64

Third Resistance

0.73

RSI

62.22

ADX

28.31

MACD

0.01

Williams % R

-5.88

Commodity Channel Index (CCI)

176.40

Date

2026-02-03

Week

89664.00

Same Day

474145.00

Month

60529.00

1 Year

0.55

3 Year

0.69

Over 1 Month

7.81%

down

Over 1 Year

-31.00%

down

Over 3 Months

7.81%

down

Over 3 Years

-6.34%

down

Over 6 Months

-2.81%

down

Over 5 Years

-16.00%

down

AMERISE BIOSCIENCES LIMITED Corporate Actions

Ex-Date Old FV NEW FV Record Date
18 Nov 2003 10.0 1.0 25 Nov 2003

Top Gainers

AMERISE BIOSCIENCES LIMITED Share Price

Amerise Biosciences Limited was initially incorporated as 'Amstar Laminates Limited' in 1984 by a private Indian party, as a specialized manufacturer of high quality construction equipment and agricultural equipment. On October 29, 2002, the name of the Company was changed from Amstar Laminates Limited to Amardeep Industries Limited and further to Amerise Biosciences Limited in August, 2021. Initially, the Company was engaged into the business of commodity trading.

During the financial year 2007 it entered into the trading of castor seeds. During the year 2024-25, due to financial crisis Company has not carried out any business activities and faces huge set back.

Parent organization Indian Private
NSE symbol [-]
Founded 1984
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Amerise Biosciences Ltd?

Answer Field

Amerise Biosciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.79 as on Feb 04 2026 03:15 PM.

What is the Market Cap of Amerise Biosciences Ltd Share?

Answer Field

The market cap of Amerise Biosciences Ltd for NSE ₹ 0.00 & for BSE ₹ 5.20 as on Feb 04 2026 03:15 PM.

What is the 52 Week High and Low of Amerise Biosciences Ltd?

Answer Field

The 52 Week High and Low of Amerise Biosciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1.06 and ₹ 0.51.

What is 1 year return for Amerise Biosciences Ltd?

Answer Field

The 1 year returns on the stock has been -31.00%.

What is the P/E Ratio of Amerise Biosciences Ltd Share?

Answer Field

As on Feb 04 2026 03:15 PM the price-to-earnings (PE) ratio for Amerise Biosciences Ltd share is 69.00.

What is the PB ratio of Amerise Biosciences Ltd Share?

Answer Field

As on Feb 04 2026 03:15 PM, the price-to-book (PB) ratio for Amerise Biosciences Ltd share is 0.80.

How to Buy Amerise Biosciences Ltd Share?

Answer Field

You can trade in Amerise Biosciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Amerise Biosciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Amerise Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Amerise Biosciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59